Carlos Serra Smith
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Carlos Serra Smith has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Ana Contreras Chicote
Neurology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain
1 shared publication - Coca-Mihaela Vieru
Department of Surgery, Complutense University of Madrid
1 shared publication - Fernando José Montero Reyes
Rheumatology Department, Hospital General Universitario Gregorio Maraňón, Madrid, Spain
1 shared publication - Francisco Arias
Pathology Department, Hospital General Universitario “Gregorio Marañón”, 28007 Madrid, Spain
1 shared publication - Isabel Herrera Herrera
Neurorradiology Section, Radiology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain
1 shared publication - Jose Manuel García Dominguez
Department of Neurology, Hospital Universitario Gregorio Marañón, 28007 Madrid, Spain
1 shared publication
Latest Publications
- 16 July 2024
- Published by Springer Nature in Neurological Sciences
- Vol. 45 (12) , 5875-5887
Rheumatoid meningitis: a case series report and review of modern therapeutic schemes and outcome
Introduction Rheumatoid meningitis (RM) is an extremely rare extra-articular complication of rheumatoid arthritis (RA), with approximately 165 cases reported world-wide. RM exhibits a broad range of symptoms, with stroke-like episodes and seizures being the most common manifestations. The primary differential diagnoses include vascular and infectious diseases. The influence of immunomodulatory medications on the pathophysiology of RM remains unclear. There are no consensus guidelines on therapeutic regimen. Methods We present four patients with prior history of RA that developed different neurological syndromes in correlation to radiological leptomeningitis. Clinical presentations, comorbid conditions, supplementary diagnostic assessments, treatments, and prognosis are provided. A literature review of recent immunosuppressive management in RM patients was performed. Results Three patients presented to hospital with recurrent focal seizures. Only two suffered meningism, reporting headache and fever. Magnetic resonance imaging (MRI) showed different grades of leptomeningitis across all cases. Notably, three cases demonstrated bilateral involvement extending to the pachymeninges. Two patients exhibited pronounced CSF mononuclear inflammation while extended microbiological evaluations yielded negative results. Two patients required biopsy for confirmation. The initiation of immunosuppressive therapy marked a turning point for three patients who previously exhibited progressive deterioration. Mortality was absent in all cases. Conclusions Our experience remarks the elusive nature of RM. Rigorous exclusionary diagnostics are imperative to differentiate RM from mimicking conditions. Clinical manifestations oscillate between transient episodes and progressive neurological impairments, punctuated by frequent epileptic seizures. In scenarios where clinical worsening persists or where clinical and radiological evaluations are inconclusive, aggressive immunosuppressive therapy is recommended.
- 16 July 2024
- Published by Springer Nature in Neurological Sciences
- Vol. 45 (12) , 5875-5887
Rheumatoid meningitis: a case series report and review of modern therapeutic schemes and outcome
Introduction Rheumatoid meningitis (RM) is an extremely rare extra-articular complication of rheumatoid arthritis (RA), with approximately 165 cases reported world-wide. RM exhibits a broad range of symptoms, with stroke-like episodes and seizures being the most common manifestations. The primary differential diagnoses include vascular and infectious diseases. The influence of immunomodulatory medications on the pathophysiology of RM remains unclear. There are no consensus guidelines on therapeutic regimen. Methods We present four patients with prior history of RA that developed different neurological syndromes in correlation to radiological leptomeningitis. Clinical presentations, comorbid conditions, supplementary diagnostic assessments, treatments, and prognosis are provided. A literature review of recent immunosuppressive management in RM patients was performed. Results Three patients presented to hospital with recurrent focal seizures. Only two suffered meningism, reporting headache and fever. Magnetic resonance imaging (MRI) showed different grades of leptomeningitis across all cases. Notably, three cases demonstrated bilateral involvement extending to the pachymeninges. Two patients exhibited pronounced CSF mononuclear inflammation while extended microbiological evaluations yielded negative results. Two patients required biopsy for confirmation. The initiation of immunosuppressive therapy marked a turning point for three patients who previously exhibited progressive deterioration. Mortality was absent in all cases. Conclusions Our experience remarks the elusive nature of RM. Rigorous exclusionary diagnostics are imperative to differentiate RM from mimicking conditions. Clinical manifestations oscillate between transient episodes and progressive neurological impairments, punctuated by frequent epileptic seizures. In scenarios where clinical worsening persists or where clinical and radiological evaluations are inconclusive, aggressive immunosuppressive therapy is recommended.